Vicenç F.
- Country
- Spain
- Department
- Infection Diseases
Research Overview
- Evaluation of Long-Acting Cabotegravir and Rilpivirine Administration in HIV-Infected Patients in Spain: Acceptability, Safety, and Feasibility Analysis
- A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in Participants With HIV-1 Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF)
Data & Insights
Has run more than one trial at 1 of 38 partner sites.
Specializations
HIV Treatment Innovation
This investigator specializes in the development and evaluation of novel therapeutic approaches for HIV-1 infection, with particular emphasis on treatment strategies for patients with recent and asymptomatic infections.
- Asymptomatic HIV Management
- Early-Stage HIV Treatment
- Novel Therapeutic Agents
Their research extends to investigating innovative drug combinations and therapeutic strategies for newly diagnosed patients.
Treatment Optimization
The investigator focuses on evaluating alternative treatment regimens, including the study of antiretroviral switching strategies and the assessment of new drug combinations for HIV management.
- Treatment Switching Protocols
- Combination Therapy Assessment
- Long-term Efficacy Studies
Their work encompasses the evaluation of treatment tolerability and sustained viral suppression in various therapeutic approaches.
Healthcare Delivery Innovation
The investigator explores new methods of treatment administration and healthcare delivery for HIV patients, including the implementation of out-of-hospital treatment protocols.
- Alternative Administration Methods
- Patient Satisfaction Assessment
- Healthcare Access Optimization
Their research includes evaluating the feasibility and acceptability of innovative treatment delivery methods in real-world settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.